After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...

Four acclaimed chefs share Christmas dishes they cook for their own families - US LIFESTYLE: Four chefs share the holiday ...

LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. New ...

So Jerry Jones did make a trade after all. The Dallas Cowboys acquired veteran linebacker Logan Wilson in a trade with the Cincinnati Bengals, NFL Network Insider Ian Rapoport reported on Tuesday, per ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Executive Editor David Carnoy ...

Serena Williams stole the show at the premiere of Gucci's short film, The Tiger, in Milan on Tuesday. The tennis legend looked ethereal in a black gown with long sleeves and feathers trimming her ...

Sept 11 (Reuters) - LB Pharmaceuticals' shares rose 27% in their Nasdaq debut on Thursday, giving the biotech firm a valuation of $381.9 million and opening the door for companies looking to tap the ...

Despite the stagnant biotech IPO market of the last six months, LB Pharmaceuticals has set out plans to reel in hundreds of millions of dollars through its upcoming public debut. The ...

Sept 8 (Reuters) - Cash-strapped drug developer LB Pharmaceuticals said on Monday it was aiming for a valuation of up to $321.6 million in its New York initial public offering, potentially setting up ...

LB Pharmaceuticals Inc. is preparing a $100 million IPO to fund Phase 3 trials for its schizophrenia drug, LB-102, after positive Phase 2 results. The company targets a large, growing schizophrenia ...